Amgen Inc. logo

Amgen Inc. (AMGN)

Market Closed
5 Dec, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
329. 89
-10.27
-3.02%
$
185.54B Market Cap
19.61 P/E Ratio
9% Div Yield
2,733,773 Volume
18.58 Eps
$ 340.16
Previous Close
Day Range
328.71 340.87
Year Range
253.3 346.38
Want to track AMGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 58 days
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 11 months ago
Amgen stock price formed a death cross: will it rebound in 2025?

Amgen stock price formed a death cross: will it rebound in 2025?

The Amgen stock price suffered a harsh reversal in the fourth quarter of 2024 as its weight loss drug failed to excite. After peaking at $341 in July, the stock plunged by over 25% to the current $260.

Invezz | 11 months ago
Amgen (AMGN) Advances While Market Declines: Some Information for Investors

Amgen (AMGN) Advances While Market Declines: Some Information for Investors

Amgen (AMGN) closed at $260.64 in the latest trading session, marking a +0.52% move from the prior day.

Zacks | 11 months ago
Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights

Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights

Amgen (AMGN) closed at $259.30 in the latest trading session, marking a -1.28% move from the prior day.

Zacks | 11 months ago
Here's Why Amgen (AMGN) Gained But Lagged the Market Today

Here's Why Amgen (AMGN) Gained But Lagged the Market Today

The latest trading day saw Amgen (AMGN) settling at $264, representing a +0.24% change from its previous close.

Zacks | 11 months ago
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.

Zacks | 11 months ago
What's Going On With Amgen Stock On Friday?

What's Going On With Amgen Stock On Friday?

On Friday, Novo Nordisk A/S NVO released headline results from the REDEFINE 1 Phase 3 trial in the global REDEFINE program.

Benzinga | 11 months ago
Viridian Therapeutics Skyrockets After Besting Amgen In Thyroid Eye Disease

Viridian Therapeutics Skyrockets After Besting Amgen In Thyroid Eye Disease

Viridian Therapeutics stock popped Monday after the company scored a win in thyroid eye disease, a condition that causes the eyes to swell. The post Viridian Therapeutics Skyrockets After Besting Amgen In Thyroid Eye Disease appeared first on Investor's Business Daily.

Investors | 11 months ago
Why Amgen (AMGN) is a Top Growth Stock for the Long-Term

Why Amgen (AMGN) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 11 months ago
Amgen (AMGN) Stock Sinks As Market Gains: Here's Why

Amgen (AMGN) Stock Sinks As Market Gains: Here's Why

Amgen (AMGN) reachead $273.41 at the closing of the latest trading day, reflecting a -0.85% change compared to its last close.

Zacks | 11 months ago
Here's Why Amgen (AMGN) is a Strong Value Stock

Here's Why Amgen (AMGN) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 0 year ago
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock

Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock

Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks | 0 year ago
Loading...
Load More